Michael Douglas Taylor, Director at Deciphera Pharmaceuticals, Inc. (DCPH), sold 40,800 shares at $55.12 ($2.3M) on 2020-04-28, disclosed to the SEC on 2020-04-30.
Open-market sale of $2.3M DCPH by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $55.12 | 1,200 | $66K | 2.9% |
| 2 | $56.31 | 11,819 | $666K | 28.8% |
| 3 | $56.31 | 11,819 | $666K | 28.8% |
| 4 | $56.96 | 3,981 | $227K | 9.8% |
| 5 | $56.96 | 3,981 | $227K | 9.8% |
| 6 | $58.00 | 8,000 |
| $464K |
| 20.0% |
| Total | $56.73 avg | 40,800 | $2.3M | 100% |
| Filing → |
| DCPH | SELL | 2021-03-03 | $655K | — | Filing → |
| DCPH | SELL | 2021-02-03 | $687K | — | Filing → |
| DCPH | SELL | 2021-01-06 | $2.1M | — | Filing → |